Skip to main content

Gloria Melanie

In the past year, 7 open-market sale filings worth $1.60M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$1.60M
7 filings
Net
−$1.60M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Gloria Melanie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

IMVT Immunovant, Inc.

Chief Operating Officer7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 21, 2026 (view filing)4:03 PM ETAug 201 dayGloria MelanieChief Operating OfficerSSale−3.06K$44.16−$135.0K−1.4%219.3K after
Jul 10, 2026 (view filing)4:15 PM ETJul 82 daysGloria MelanieChief Operating OfficerSSale−2.04K$39.55−$80.5K−0.9%222.4K after2 lots
Jun 26, 2026 (view filing)Jun 26Same dayGloria MelanieChief Operating OfficerSSale−17.7K$38.31−$678.6K−7.3%224.4K after2 lots
May 22, 2026 (view filing)May 202 daysGloria MelanieChief Operating OfficerSSale−3.12K$32.45−$101.1K−1.3%242.1K after3 lots
Apr 10, 2026 (view filing)Apr 82 daysGloria MelanieChief Operating OfficerSSale−8.72K$24.83−$216.6K−3.4%245.2K after
Feb 27, 2026 (view filing)Feb 252 daysGloria MelanieChief Operating OfficerSSale−3.24K$27.85−$90.2K−1.9%170.3K after3 lots
Nov 21, 2025 (view filing)Nov 201 dayGloria MelanieChief Operating OfficerSSale−12.6K$23.62−$298.2K−6.8%173.5K after2 lots